JM Midcap Fund Regular Growth

+

Equity
Mid-Cap
Rating N.A.
Plan

19.82 +0.06 (0.31%) NAV as on 09 Dec, 2024

5D
1M
6M
1Y
5Y
MAX

Key Metrics

AUM (in Cr)1691.09
CAGR 39.02%
Exit Load1.00%
Expense ratio1.99%
CategoryEquity
Min Investment1000
Min SIP500
Launch Date2022-11-21

Asset Allocation

Holdings As On - 11 December 2024

Holdings

Sectors

Name
Value (Cr)
Holding %

IPCA Laboratories
60.46
3.57%

Tata Technologies
48.81
2.89%

Biocon
43.29
2.56%

Fortis Healthcare
43.27
2.56%

Berger Paints India
42.95
2.54%

JSW Infrastructure
42.68
2.52%

Federal Bank
41.91
2.48%

Peer Comparison

Fund Name
Baroda BNP Paribas Mid Cap Fund Regular Plan Growth33.92%
Union Midcap Fund Regular Growth32.11%
WhiteOak Capital Mid Cap Fund Regular Growth38.84%
JM Midcap Fund Regular Growth39.02%
Bandhan Midcap Fund Regular Growth37.44%

Risk & Volitility

Alpha 0.00%
Beta 0.00
Sharpe Ratio0.00
Std Deviation 0.00%
Tracking Error 0.00%

About Fund

To provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies.

The JM Midcap Fund Regular Growth has an AUM of 1691.09 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.99%. The minimum investment in JM Midcap Fund Regular Growth is Rs 1000 and the minimum SIP is Rs 500.

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

The top holdings of the fund include IPCA Laboratories, Max Healthcare Institute, Tata Technologies & Glenmark Pharmaceuticals.

The major sectors where the fund is invested are Biotechnology & Drugs, Chemical Manufacturing, Healthcare Facilities & Misc. Capital Goods.

Some of the similar funds are Baroda BNP Paribas Mid Cap Fund Regular Plan Growth, Union Midcap Fund Regular Growth, WhiteOak Capital Mid Cap Fund Regular Growth, JM Midcap Fund Regular Growth, Bandhan Midcap Fund Regular Growth. JM Midcap Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.